Canonsburg, Pa.-based Mylan, a leading generic drugmaker, is buying Agila Specialties Private Ltd. in an all cash deal that is expected to close in the fourth quarter.
The acquisition offered Mylan the chance to expand its existing injectables product portfolio and enter new high-growth markets, the company said in a
Skadden New York partners Marie Gibson and Eric Cochran, leading a team of lawyers that also includes partners in Washington, D.C., and London, are acting for Mylan on the transaction, with
Slaughter and May also playing an advisory role for the company.
Herbert Smith Freehills London partner Alan Montgomery is representing Strides Arcolab. Indian firm
DSK Legal served as local counsel.
As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters.
Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss.
Tailored just for you. In your inbox. Every day.